×

Ichan gets say in Lionsgate vote

Mogul will get vote on poison pill provision

Lionsgate will include Carl Ichan as a voter in its upcoming shareholder vote on a poison pill that’s designed to make it more difficult for Icahn to complete a hostile takeover of the minimajor.

Lionsgate made the announcement Friday, a week and a half before the May 4 vote on the pill — dubbed a shareholder rights plan — at a meeting in Toronto.

“We listen carefully to what our shareholders have to say, and we believe that this was a revision many of them wanted to see,” a Lionsgate spokesman said. “We believe that the proposed Shareholder Rights Plan is in our shareholders’ best interest, and we are delighted that two respected proxy advisory firms, Glass Lewis and Egan Jones, agree.”

Icahn, who owns about 19% of Lionsgate, boosted his bid to $7 a share from $6 on April 15. The company repeated its characterizations Friday of Icahn’s offer as inadequate, opportunistic and coercive.

In a letter sent to shareholders Friday, Lionsgate said the shareholder rights plan has been created to ensure that all shareholders are treated fairly in connection with any proposals to acquire effective control of the company.

The Shareholder Rights Plan your Board is recommending does not prevent change of control transactions,” the letter said. “By design, the Shareholder Rights Plan does not prevent or restrict a proxy challenge, but deters inadequate, opportunistic and coercive offers, such as the offer by the Icahn Group.”

Shares of Lionsgate were up 18 cents to $7.07 in mid-session trading Friday on the New York Stock Exchagne.

Should Icahn’s stake exceed 20%, it could trigger a possible default of its credit line. The company’s poison-pill provision would dilute the value of Icahn’s shares if he exceeds a 20% stake.

The letter also took issue with a recommendation issued Thursday by proxy advisory firm RiskMetrics to vote against the pill, partly due to Icahn’s shares not being counted in the voting. Icahn cited that recommendation in a letter issued an announcement Friday and said the process is still flawed despite Lionsgate’s revision — noting that holders of any shares purchased after the March 23 record date won’t be able to vote.

In a last ditch effort to salvage the Pill, the board today announced certain amendments to the Pill,” Icahn said. “This changes nothing. The Pill and the “voting” process are still gravely deficient and unfair. The board has intentionally structured the special meeting so as to maximize the likelihood that the views of the board will be imposed on those Lions Gate shareholders who would otherwise tender their shares in our offer.”

Frustrated by the stagnant stock price that’s barely half of its 2007 high, Icahn’s argued that Lionsgate’s management and board of directors has “failed” and pledged that he will oust the current management team if he gains control. He’s also said his offer represents a “premium” valuation for the assets.

Lionsgate is home to the “Saw” and Tyler Perry franchises, as well as TV shows “Mad Men” and “Weeds.” Its superhero spoof “Kick-Ass” led last weekend’s box office and has grossed $24.2 million in its first six days.

Popular on Variety

More Film

  • Incitement

    'Incitement' Wins Ophir Award for Best Picture, Becomes Israel's Oscar Submission

    “Incitement” was the best-picture winner at Israel’s Ophir Awards on Sunday night, automatically becoming the country’s choice to vie for the international feature film Oscar. The winning film, a drama about the period leading up to the assassination of Israeli Prime Minister Yitzhak Rabin by a Jewish extremist in 1995, had its global premiere at [...]

  • LargoAI

    LargoAI Wins Inaugural San Sebastian Zinemaldia & Technology Startup Challenge

    SAN SEBASTIAN  —  Swiss artificial intelligence and data analytics company LargoAI won Sunday’s first-ever San Sebastian Film Festival Zinemaldia & Technology Startup Challenge. LargoAI’s software provides data-driven filmmaking strategies, similar to those used by major VOD platforms which aggregate and often horde their own user-driven data. From early in the screenwriting process through development and [...]

  • MARIANA-RONDÓN-MARITÉ-UGÁS

    FiGa Snags 'Contactado,' By The Team Behind San Sebastian Winner 'Pelo Malo' (EXCLUSIVE)

    Sandro Fiorin’s FiGa Films has picked up worldwide sales rights to “Contactado,” the upcoming feature by Sudaca Films’ Marité Ugás and Mariana Rondón, the duo behind San Sebastian 2013 Golden Shell winner, “Pelo Malo.” The Sudaca partners are attending San Sebastian to pitch Rondón-helmed project “Zafari” at the 8th Europe-Latin American Co-production Forum. Directed by [...]

  • Brad Pitt stars in “Ad Astra”.

    'Ad Astra' Lifts Above Competition at International Box Office With $26 Million

    Though “Ad Astra” was overthrown by the Crawley family at the domestic box office, Brad Pitt’s astronaut drama reigned supreme at the international box office. Directed by James Gray, “Ad Astra” launched overseas with $26 million from 44 foreign markets. The $80 million sci-fi epic debuted in North America with $19.2 million, bringing global box [...]

  • hugh jackman tiff bad education

    Toronto's Biggest Deal Goes to HBO: A Sign of the Future? (Column)

    When it comes to how we’ll be watching movies — or, at least, watching serious dramas for adults — in the future, here are two stark and timely contradictory facts: 1. Last week, as the Toronto International Film Festival drew to a close, a deal that had been in the rumor stage for a while [...]

  • 'Talking About Trees' Helmer Suhaib Gasmelbari

    'Talking About Trees' Director Suhaib Gasmelbari Receives Variety MENA Award

    Suhaib Gasmelbari, whose Sudanese documentary “Talking About Trees” premiered in the Berlinale’s Panorama section, received the Variety Middle East and North Africa Region Talent Award Saturday at the El Gouna Film Festival in Egypt from festival director Intishal Al Timimi. Variety critic Jay Weissberg, who selected the honoree, said that it is not usual that [...]

More From Our Brands

Access exclusive content